Cross-Site Severity Assessment of COVID-19 from CT Images via Domain Adaptation
Geng-Xin Xu, Chen Liu, Jun Liu, Zhongxiang Ding, Feng Shi, Man Guo,, Wei Zhao, Xiaoming Li, Ying Wei, Yaozong Gao, Chuan-Xian Ren, Dinggang Shen

TL;DR
This paper introduces a novel domain adaptation method for COVID-19 severity assessment from CT images that addresses class imbalance, domain discrepancy, and heterogeneous features to improve cross-site classification accuracy.
Contribution
It proposes a two-component domain adaptation framework combining class-balanced boosting sampling and representation learning with prototype triplet loss, MMD loss, and multi-view reconstruction.
Findings
Outperforms recent domain adaptation methods on cross-site COVID-19 severity assessment
Effectively handles class imbalance and domain discrepancies
Improves generalization across different data collection sites.
Abstract
Early and accurate severity assessment of Coronavirus disease 2019 (COVID-19) based on computed tomography (CT) images offers a great help to the estimation of intensive care unit event and the clinical decision of treatment planning. To augment the labeled data and improve the generalization ability of the classification model, it is necessary to aggregate data from multiple sites. This task faces several challenges including class imbalance between mild and severe infections, domain distribution discrepancy between sites, and presence of heterogeneous features. In this paper, we propose a novel domain adaptation (DA) method with two components to address these problems. The first component is a stochastic class-balanced boosting sampling strategy that overcomes the imbalanced learning problem and improves the classification performance on poorly-predicted classes. The second component…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
